Neurobiological Technologies, Inc. (NTII)

OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Nov 14, 2025
Market Cap27.00 -100.0%
Revenue (ttm)25.32M +77.6%
Net Income18.67M
EPS0.69
Shares Out27.02M
PE Ratio0.00
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,429
Average Volume185,062
Open0.0000
Previous Close0.0001
Day's Range0.0000 - 0.0000
52-Week Range0.0000 - 0.0001
Beta-572.90
RSI45.45
Earnings Daten/a

About NTII

Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1987
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol NTII
Full Company Profile

Financial Performance

Financial Statements